GenMark Diagnostics (GNMK) Tops Q4 EPS by 6c
Tweet Send to a Friend
GenMark Diagnostics (NASDAQ: GNMK) reported Q4 EPS of ($0.15), $0.06 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
